Fundz

4P-Pharma secured €15 million in a private equity round to develop curative therapies for untreated serious diseases

PRIVATEApr 29, 2024

Amount Raised

€15 Million

Round Type

Private Equity

Biotechnology

Description

4P-Pharma, a Lille-based clinical-stage startup studio, has announced the successful securing of a total capital of €15 million in its second closing with participation from private investors. The funding will support the company's drug regeneration model for untreated serious diseases and enable it to engage actively in external growth opportunities through M&A and licensing-in.

Who else raised in Biotechnology around the same time

Companies in the same sectors as 4P-Pharma that raised within 45 days of this round, from Fundz verified event records.

  • UPyTher raised $1.5M (Seed) on June 13, 2024.
  • InduPro raised $85M (Series A) on June 13, 2024.
  • Greenwich LifeSciences raised $2.5M (Seed) on June 13, 2024.
  • Alida Biosciences Inc. raised $7.5M (Series A) on June 12, 2024.
  • Rivia raised $3.2M (Seed) on June 12, 2024.
  • Alzheon raised $100M (Series E) on June 12, 2024.

Who to call at 4P-Pharma, and when

A new round usually means 4P-Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day 4P-Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at 4P-Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at 4P-Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

4P-Pharma

About

Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.​ Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.​ We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment 4P-Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for 4P-Pharma's next move

See what Strategic adds

4P-Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.